Clinical Trials Browser

Phase 2 × Recruiting × Gastric/Gastroesophageal Junction Adenocarcinoma × Clear all

NCT06774222 2025-01-14

A Study of Fruquintinib Plus Chemotherapy for Postoperative Treatment of HER2-Negative Gastric Cancer With Poor TRG

Phase 2 Recruiting

Gastrointestinal

Gastric/Gastroesophageal Junction Adenocarcinoma